Compare PAAC & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PAAC | NAGE |
|---|---|---|
| Founded | 2025 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 179.0M | 212.8M |
| IPO Year | 2025 | 2010 |
| Metric | PAAC | NAGE |
|---|---|---|
| Price | $10.01 | $2.48 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $12.08 |
| AVG Volume (30 Days) | 42.6K | ★ 535.9K |
| Earning Date | N/A | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.82 |
| EPS | N/A | ★ 0.09 |
| Revenue | N/A | ★ $129,423,000.00 |
| Revenue This Year | N/A | $2.91 |
| Revenue Next Year | N/A | $16.17 |
| P/E Ratio | ★ N/A | $27.83 |
| Revenue Growth | N/A | ★ 29.95 |
| 52 Week Low | $9.93 | $2.39 |
| 52 Week High | $10.15 | $7.95 |
| Indicator | PAAC | NAGE |
|---|---|---|
| Relative Strength Index (RSI) | 42.01 | 36.17 |
| Support Level | $9.97 | N/A |
| Resistance Level | $10.04 | $3.61 |
| Average True Range (ATR) | 0.01 | 0.08 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 4.87 | 33.18 |
Proem Acquisition Corp I is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.